Article Text

Download PDFPDF
Rare disease
Stage IV malignant melanoma of unknown primary site in a young man
  1. Petros Christopoulos,
  2. Triantafyllos Doulias,
  3. Ioannis Koutelidakis,
  4. Bassileios Papaziogas
  1. 2nd Surgical Unit, G. Gennimatas Hospital, Thessaloniki, Greece
  1. Correspondence to Dr Triantafyllos Doulias, tdoulias{at}yahoo.com

Metastatic melanoma of unknown primary is a rare entity with low life expectancy. Inoperable metastatic malignant melanoma in lungs has a survival rate of <6%. Regression of the primary lesion is a well-documented theory in the literature, since melanoma is one of the tumours that can undergo regression. We present a case of a young man with metastatic malignant melanoma in lungs, whose survival duration is longer than expected even without metastasectomy.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Competing interests None.

  • Patient consent Obtained.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.